ABBV / AbbVie Inc

Abbvie Inc, headquartered in North Chicago, Illinois, was established in 2013 following its spin-off from Abbott Laboratories. The company specializes in the research, development, and commercialization of innovative medicines, particularly in areas such as immunology, oncology, and neuroscience. Abbvie's flagship product, Humira, has been a leading treatment for autoimmune diseases. The company continues to expand its pipeline through research and strategic acquisitions, aiming to address unmet medical needs worldwide.